Press releases
2023
27 Nov 2023, 07:00 | Regulatory
26 Oct 2023, 07:00 | Regulatory
• Encouraging high-level results for first-in-human trial of HNSA-5487
• Well attended Hansa-sponsored symposium at ESOT focusing on first patient experiences
• Dr. Hitto Kaufmann appointed new CSO
• Well attended Hansa-sponsored symposium at ESOT focusing on first patient experiences
• Dr. Hitto Kaufmann appointed new CSO
17 Oct 2023, 07:00
11 Oct 2023, 18:35 | Regulatory
Biologic License Application submission expected for 2025
9 Oct 2023, 17:35
HNSA-5487 is a next-generation IgG-cleaving enzyme and the lead candidate in the NiceR development program
1 Sep 2023, 12:00 | Regulatory
31 Jul 2023, 08:00 | Regulatory
20 Jul 2023, 07:00 | Regulatory
· Solid product sales in Q2 2023
· Collaboration announced in gene therapy with Genethon in Crigler-Najjar syndrome
· New Eurotransplant desensitization program implemented in June
· First patient treated in new investigator-initiated Phase 2 study in ANCA-associated vasculitis
